Skip to main navigation Skip to search Skip to main content

Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia

  • Aaron D. Schimmer
  • , Elihu H. Estey
  • , Gautam Borthakur
  • , Bing Z. Carter
  • , Gary J. Schiller
  • , Martin S. Tallman
  • , Jessica K. Altman
  • , Judith E. Karp
  • , Jeannine Kassis
  • , David W. Hedley
  • , Joseph Brandwein
  • , Wei Xu
  • , Duncan H. Mak
  • , Eric LaCasse
  • , Christine Jacob
  • , Stephen J. Morris
  • , Jacques Jolivet
  • , Michael Andreeff

Research output: Contribution to journal › Article › peer-review

98   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science